Statin drugs, serum cholesterol, and prostate-specific antigen in the national health and nutrition examination survey 2001-2004

Cancer Causes and Control

Volumn 21, Issue 5, 2010, Pages 671-678

  Mondul, Alison M ^a   Selvin, Elizabeth ^a,b   De Marzo, Angelo M ^c,d,e   Freedland, Stephen J ^f   Platz, Elizabeth A ^a,d,e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Cholesterol; Cross sectional studies; Hydroxymethylglutaryl CoA reductases; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

ATORVASTATIN; CERIVASTATIN; CHOLESTEROL; COLESTYRAMINE; EZETIMIBE; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; PROSTATE SPECIFIC ANTIGEN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD ANALYSIS; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; HEALTH SURVEY; HEART INFARCTION; HISPANIC; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; RACE DIFFERENCE; STROKE; SYSTEMATIC ERROR; BLOOD; DELAYED DIAGNOSIS; MIDDLE AGED; NUTRITION; PROSTATE TUMOR;

CHOLESTEROL; DELAYED DIAGNOSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; NUTRITION SURVEYS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 77955286539     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9494-9     Document Type: Article

References (22)

1. Shannon J, Tewoderos S, Garzotto M et al (2005) Statins and prostate cancer risk: a case-control study. Am J Epidemiol 162(4):318-325
2. Platz EA, Leitzmann MF, Visvanathan K et al (2006) Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 98(24):1819-1825
3. Flick ED, Habel LA, Chan KA et al (2007) Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev 16(11):2218-2225
4. Jacobs EJ, Rodriguez C, Bain EB et al (2007) Cholesterol-lowering drugs and advanced prostate cancer incidence in a large US cohort. Cancer Epidemiol Biomarkers Prev 16(11):2213-2217
5. Murtola TJ, Tammela TL, Lahtela J, Auvinen A (2007) Cholesterol- lowering drugs and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 16(11): 2226-2232
6. Friedman GD, Flick ED, Udaltsova N et al (2008) Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients. Pharmacoepidemiol Drug Saf 17(1):27-36
7. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM (2005) Statins and cancer prevention. Nat Rev Cancer 5(12): 930-942
8. Solomon KR, Freeman MR (2008) Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab 19(4):113-121
9. Platz EA, Clinton SK, Giovannucci E (2008) Association between plasma cholesterol and prostate cancer in the PSA era. Int J Cancer 123(7):1693-1698
10. Platz EA, Till C, Goodman PJ et al. (2009) Men with low serum cholesterol have a lower risk of high grade prostate cancer in the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev (in press)
11. Mondul AM, Clipp SL, Helzlsouer KJ, Platz EA (2009) Association of plasma total cholesterol concentration with incident prostate cancer in the CLUE II Cohort. Cancer causes and control 2009 Oct 6 [epub ahead of print]
12. Cyrus-David MS, Weinberg A, Thompson T, Kadmon D (2005) The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report. J Urol 1923-1925
13. Hamilton RJ, Goldberg KC, Platz EA, Freedland SJ (2008) The influence of statin medications on prostate-specific antigen levels. J Natl Cancer Inst 100(21):1511-1518
14. Merrill RM, Perego UA, Heiner SW (2002) Age, lifestyle, health risk indicators, and prostate-specific antigen scores in men participating in the world senior games. Urol Oncol 7(3):105-109
15. Mills IA, Crossland A, Patel A, Ramonas H (2007) Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement. Eur Urol 52:503-509
16. Total Prostate-Specific Antigen in Serum NHANES 2003-2004. Report. National Institutes of Health, Hyattsville, MD, 2008
17. Total Cholesterol, Direct HDL, Precipitated HDL, Triglycerides, and LDL NHANES 2003-2004. Report. National Institutes of Health, Hyattsville, MD, 2008
18. Analytic and Reporting Guidelines: The National Health and Nutrition Examination Survey (NHANES) (2006) National Center for Health Statistics, Hyattsville, MD
19. Consultation WHOE (2000) Obesity: preventing and managing the global epidemic: report of a WHO consultation. Geneva, Switzerland
20. Lazo M, Selvin E, Clark JM (2008) Brief communication: clinical implications of short-term variability in liver function test results. Ann Intern Med 148(5):348-352
21. Yi S, Selvin E, Rohrmann S et al (2009) Endogenous sex steroid hormones and measures of chronic kidney disease in a nationally representative sample of men. Clin Endocrinol 71(2):246-252
22. Rosenbaum PR, Rubin DB (1984) Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79(387):516-524